The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

Function Health raised a $298 million Series B round, pushing its valuation into unicorn territory at $2.5 billion. The ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

Amid growing pressure on the U.S. healthcare system to meet the needs of its aging population, the Digital Medicine Society (DiMe) launched a new initiative this month to build a roadmap for ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

The Food and Drug Administration will remove black box warnings from hormone replacement therapy (HRT) products, which are often used to treat menopause, the Department of Health and Human Services ...

Provider organizations are continuing to adopt AI tools across their departments and clinics, and ambient documentation startups are facing the challenge of differentiating themselves in a field ...

An experimental MeiraGTx gene therapy that has clinical data showing reversal of blindness in children born with a rare, inherited eye disorder is heading to Eli Lilly. According to the terms of the ...

As the nation’s healthcare industry continues to struggle with workforce shortages and access gaps, Philips is expanding beyond its traditional medtech roots. The company isn’t just selling monitoring ...

How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are ...

From L to R Paige Minemyer, Senior Writer, Fierce Healthcare; Dr. James Metcalf, Regional Chief Medical Officer, Medicare & Retirement, Optum; Puneet Maheshwari, GM, Optum Real; Pete Clardy, Senior ...